MALLORY MOORE: Open Payments
NPI 1740864180 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,264 in 113 payments from 13 companies in 2025. Trend: 2023 $1,090 · 2024 $1,234 · 2025 $2,264
Food & beverage: $2,264
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $587 |
| Madrigal Pharmaceuticals | 15 | $548 |
| Ardelyx, Inc. | 12 | $223 |
| Janssen Biotech, Inc. | 10 | $194 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $165 |
| GENZYME CORPORATION | 6 | $131 |
| Phathom Pharmaceuticals, Inc. | 16 | $125 |
| Regeneron Healthcare Solutions, Inc. | 4 | $93 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| Gilead Sciences, Inc. | 2 | $50 |
Products named: REZDIFFRA, RINVOQ, DUPIXENT, IBSRELA, TREMFYA, SKYRIZI, ENTYVIO, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
